tiprankstipranks
Trending News
More News >
Sakai Chemical Industry Co., Ltd. (JP:4078)
:4078
Japanese Market

Sakai Chemical Industry Co., Ltd. (4078) AI Stock Analysis

Compare
0 Followers

Top Page

JP

Sakai Chemical Industry Co., Ltd.

(4078)

Rating:71Outperform
Price Target:
¥2,821.00
▲(5.93%Upside)
Sakai Chemical Industry Co., Ltd. achieves a strong overall score driven by robust financial performance and an attractive valuation profile. The company's effective cash flow management and profitability improvements are significant strengths. Technical indicators present a mixed picture, with signs of bullish momentum but some caution due to oversold conditions.

Sakai Chemical Industry Co., Ltd. (4078) vs. iShares MSCI Japan ETF (EWJ)

Sakai Chemical Industry Co., Ltd. Business Overview & Revenue Model

Company DescriptionSakai Chemical Industry Co., Ltd. (4078) is a Japanese company primarily engaged in the manufacture and sale of chemical products. The company operates in various sectors, including electronics, pharmaceuticals, and industrial chemicals. Its core products include pigments, stabilizers, and other chemical additives that are used in a wide range of applications such as plastics, coatings, and electronics.
How the Company Makes MoneySakai Chemical Industry Co., Ltd. generates revenue through the production and sale of its chemical products. The company sells its products to various industries, including electronics, automotive, and pharmaceuticals, which require specialized chemical materials for manufacturing and product development. Key revenue streams for Sakai include the sales of pigments and stabilizers used in plastics and coatings, as well as advanced materials for electronic components. Partnerships with major manufacturers in these sectors also contribute to the company's earnings by providing a steady demand for its products. Additionally, Sakai may engage in research and development activities to innovate and expand its product offerings, thereby creating new revenue opportunities.

Sakai Chemical Industry Co., Ltd. Financial Statement Overview

Summary
Sakai Chemical Industry Co., Ltd. exhibits a solid financial performance with improved profitability and strong cash flow generation. The balance sheet is robust with low leverage, though there may be opportunities to optimize capital structure for enhanced growth.
Income Statement
72
Positive
Sakai Chemical Industry Co., Ltd. shows a strong recovery in profitability with a net income of 5,014 million yen and a gross profit margin of 24.02%. The revenue growth rate is modest at 2.8%, indicating stable sales. The EBIT margin has significantly improved from the previous year, rising to 7.22%, while the EBITDA margin stands at 11.56%. Despite the positive trends, the volatility in net income observed in prior years poses a potential risk.
Balance Sheet
65
Positive
The company's financial leverage is moderate with a debt-to-equity ratio of 0.28, which is a positive indicator of financial health. Return on Equity has improved significantly to 6.4%, reflecting better profitability for shareholders. However, the equity ratio remains relatively high at 63.5%, suggesting a conservative capital structure but potentially underutilized leverage in growth initiatives.
Cash Flow
78
Positive
The cash flow situation is robust, with a substantial increase in free cash flow to 5,057 million yen, representing a growth rate of 77.9%. The operating cash flow to net income ratio is strong at 2.39, indicating efficient cash generation from operations. While free cash flow to net income ratio at 1.01 suggests effective conversion of profits into cash, the company has significantly improved its cash flow management.
Breakdown
TTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income StatementTotal Revenue
84.92B84.41B82.11B83.86B80.14B84.92B
Gross Profit
19.91B20.28B16.86B18.48B21.05B17.22B
EBIT
5.92B6.09B2.94B4.41B7.49B4.30B
EBITDA
9.57B9.76B892.00M9.61B13.76B2.43B
Net Income Common Stockholders
4.10B5.01B-7.09B2.34B6.75B-2.80B
Balance SheetCash, Cash Equivalents and Short-Term Investments
15.07B16.18B16.59B12.41B10.80B11.09B
Total Assets
125.24B123.32B125.44B128.02B123.92B123.01B
Total Debt
23.80B21.92B27.04B21.64B16.96B20.44B
Net Debt
8.73B5.74B10.45B9.23B6.16B9.35B
Total Liabilities
47.44B43.93B49.98B43.31B41.21B43.74B
Stockholders Equity
76.84B78.29B74.39B80.49B78.85B75.80B
Cash FlowFree Cash Flow
0.005.06B2.84B-1.89B1.50B-1.74B
Operating Cash Flow
0.0012.01B6.87B773.00M6.57B7.83B
Investing Cash Flow
0.00-5.71B-3.96B-2.62B-1.65B-7.42B
Financing Cash Flow
0.00-6.88B1.26B3.28B-5.65B1.67B

Sakai Chemical Industry Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2663.00
Price Trends
50DMA
2525.90
Positive
100DMA
2573.77
Positive
200DMA
2553.97
Positive
Market Momentum
MACD
28.98
Negative
RSI
57.06
Neutral
STOCH
67.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4078, the sentiment is Positive. The current price of 2663 is above the 20-day moving average (MA) of 2590.75, above the 50-day MA of 2525.90, and above the 200-day MA of 2553.97, indicating a bullish trend. The MACD of 28.98 indicates Negative momentum. The RSI at 57.06 is Neutral, neither overbought nor oversold. The STOCH value of 67.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4078.

Sakai Chemical Industry Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥216.88B20.42
1.13%4.85%35.53%
75
Outperform
¥74.08B8.43
4.58%4.87%5.12%
71
Outperform
¥44.89B8.61
5.15%3.16%
66
Neutral
¥60.54B9.73
4.56%3.21%-1.94%
66
Neutral
¥48.14B14.82
2.02%-3.73%
51
Neutral
$2.04B-1.15-21.24%3.95%2.91%-30.44%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4078
Sakai Chemical Industry Co., Ltd.
2,632.00
-76.20
-2.81%
JP:4008
Sumitomo Seika Chemicals Co., Ltd.
4,425.00
-473.45
-9.67%
JP:4028
ISHIHARA SANGYO KAISHA, LTD.
1,877.00
373.64
24.85%
JP:4046
OSAKA SODA CO.,LTD.
1,704.00
-228.16
-11.81%
JP:4047
Kanto Denka Kogyo Co., Ltd.
862.00
-42.50
-4.70%

Sakai Chemical Industry Co., Ltd. Corporate Events

Sakai Chemical Industry Reports Zero Share Acquisition
Jun 2, 2025

Sakai Chemical Industry Co., Ltd. announced that it has not acquired any of its own shares during the specified acquisition period from May 15, 2025, to May 31, 2025, despite having resolved to purchase up to 1,000,000 shares. The acquisition plan, which was approved by the Board of Directors, aimed to enhance shareholder value but has yet to be executed, leaving the total number of shares acquired at zero.

Sakai Chemical Industry Announces Share Buyback to Boost Shareholder Value
May 14, 2025

Sakai Chemical Industry Co., Ltd. has announced a decision by its Board of Directors to acquire up to 1,000,000 of its own shares, representing 6.17% of its total issued shares, excluding treasury shares. This move, which will take place between May 15, 2025, and November 30, 2025, aims to improve shareholder value per share and capital efficiency. The acquisition will be conducted through market purchases on the Tokyo Stock Exchange and the Off-Auction Own Share Repurchase Trading System. Following the acquisition, the company plans to cancel all the treasury shares acquired, further optimizing its capital structure.

Sakai Chemical Industry Proposes Amendments to Articles of Incorporation
May 14, 2025

Sakai Chemical Industry Co., Ltd. has announced a proposal to amend its Articles of Incorporation by reducing the maximum number of directors from 15 to 11. This change aims to enhance management agility and strengthen corporate governance by aligning the number of directors with the current operational needs, following improvements in their executive officer system introduced in 2021.

Sakai Chemical Reports Strong Financial Recovery in FY 2025
May 14, 2025

Sakai Chemical Industry Co., Ltd. reported a significant improvement in its financial performance for the fiscal year ending March 2025, with a 2.8% increase in net sales and a dramatic rise in operating profit by 107.1%. The company’s comprehensive income also turned positive, reflecting a strong recovery from the previous year’s losses, indicating a positive impact on its operations and market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.